Literature DB >> 36180807

Risk of meningitis after posterior fossa decompression with duraplasty using different graft types in patients with Chiari malformation type I and syringomyelia: a systematic review and meta-analysis.

Omar F Jbarah1, Bahaa I Aburayya2, Ayman R Shatnawi2, Mohab A Alkhasoneh2, Ahmad A Toubasi3, Sondos M Alharahsheh2, Saleem K Nukho2, Asil S Nassar2, Mohammad A Jamous4.   

Abstract

Several complications have been reported after the use of grafts for duraplasty following posterior fossa decompression for the treatment of Chiari malformation type I. This study aims to investigate the rate of meningitis after posterior fossa decompression using different types of grafts in patients with Chiari malformation type I and associated syringomyelia. The search was conducted using multiple databases, including PubMed, Scopus, Web of Science, and Embase. Data on the rate of meningitis, syrinx change, and rate of reoperation were extracted and investigated. Quality of evidence was assessed using the Newcastle-Ottawa scale. Nineteen studies were included in the final meta-analysis, encompassing 1404 patients and investigating autografts, synthetic grafts, allografts, and xenografts (bovine collagen, bovine pericardium, and pig pericardium). Autografts were associated with the lowest rate of meningitis (1%) compared to allografts, synthetic grafts, and xenografts (2%, 5%, and 8% respectively). Autografts were also associated with the lowest rate of reoperation followed by xenografts, allografts, and synthetic grafts (4%, 5%, 9%, and 10% respectively). On the other hand, allografts were associated with the highest rate of syrinx improvement (83%) in comparison to autografts and synthetic grafts (77%, and 79% respectively). Autografts were associated with the lowest meningitis, reoperation, and syrinx improvement rates. Furthermore, synthetic grafts were associated with the highest reoperation and xenografts with the highest rate of meningitis, whereas allografts were associated with the best syrinx improvement rate and second-best meningitis rate. Future studies comparing autografts and allografts are warranted to determine which carries the best clinical outcome.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Chiari malformation; Duraplasty; Meningitis; Posterior fossa decompression; Syringomyelia

Year:  2022        PMID: 36180807     DOI: 10.1007/s10143-022-01873-6

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   2.800


  28 in total

Review 1.  Comparison of Results Between Posterior Fossa Decompression with and without Duraplasty for the Surgical Treatment of Chiari Malformation Type I: A Systematic Review and Meta-Analysis.

Authors:  Weiwei Lin; Guman Duan; Jinjin Xie; Jiashen Shao; Zhaoqi Wang; Baohua Jiao
Journal:  World Neurosurg       Date:  2017-11-11       Impact factor: 2.104

2.  Comparison of Clinical and Radiographic Outcomes for Posterior Fossa Decompression with and without Duraplasty for Treatment of Pediatric Chiari I Malformation: A Prospective Study.

Authors:  Enze Jiang; Shifu Sha; XinXin Yuan; WeiGuo Zhu; Jian Jiang; Hongbin Ni; Zhen Liu; Yong Qiu; Zezhang Zhu
Journal:  World Neurosurg       Date:  2017-11-10       Impact factor: 2.104

3.  Outcomes of dura-splitting technique compared to conventional duraplasty technique in the treatment of adult Chiari I malformation: a systematic review and meta-analysis.

Authors:  Amin Tavallaii; Ehsan Keykhosravi; Hamid Rezaee; Mohammad Ali Abouei Mehrizi; Ahmad Ghorbanpour; Ali Shahriari
Journal:  Neurosurg Rev       Date:  2020-06-22       Impact factor: 3.042

4.  Presentation and management of Chiari I malformation in children.

Authors:  J K Park; P L Gleason; J R Madsen; L C Goumnerova; R M Scott
Journal:  Pediatr Neurosurg       Date:  1997-04       Impact factor: 1.162

5.  Cerebrospinal fluid-related complications with autologous duraplasty and arachnoid sparing in type I Chiari malformation.

Authors:  Caitlin E Hoffman; Mark M Souweidane
Journal:  Neurosurgery       Date:  2008-03       Impact factor: 4.654

6.  Surgical treatment of syringomyelia based on magnetic resonance imaging criteria.

Authors:  T H Milhorat; W D Johnson; J I Miller; R M Bergland; J Hollenberg-Sher
Journal:  Neurosurgery       Date:  1992-08       Impact factor: 4.654

7.  Clinical and radiological outcomes of arachnoid-preseving suboccipital decompression for adult chiari I malformation with and without syringomyelia.

Authors:  Rahsan Kemerdere; Mehmet Yigit Akgun; Semih Can Cetintas; Tibet Kacira; Taner Tanriverdi
Journal:  Clin Neurol Neurosurg       Date:  2019-11-12       Impact factor: 1.876

8.  Surgical management of patients with Chiari I malformation.

Authors:  John Siasios; Eftychia Z Kapsalaki; Kostas N Fountas
Journal:  Int J Pediatr       Date:  2012-06-28

Review 9.  Malformations of the craniocervical junction (Chiari type I and syringomyelia: classification, diagnosis and treatment).

Authors:  Alfredo Avellaneda Fernández; Alberto Isla Guerrero; Maravillas Izquierdo Martínez; María Eugenia Amado Vázquez; Javier Barrón Fernández; Ester Chesa i Octavio; Javier De la Cruz Labrado; Mercedes Escribano Silva; Marta Fernández de Gamboa Fernández de Araoz; Rocío García-Ramos; Miguel García Ribes; Carmen Gómez; Joaquín Insausti Valdivia; Ramón Navarro Valbuena; José R Ramón
Journal:  BMC Musculoskelet Disord       Date:  2009-12-17       Impact factor: 2.362

10.  Long-term outcomes of posterior fossa decompression for Chiari malformation type 1: which patients are most prone to failure?

Authors:  Khashayar Mozaffari; Laurence Davidson; Eric Chalif; Tiffany N Phan; Andrew D Sparks; John S Myseros; Chima O Oluigbo; Robert F Keating
Journal:  Childs Nerv Syst       Date:  2021-07-07       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.